#United States #Terumo Medical #Somerset #SurTract #SafeR Technology

Terumo Launches SurTract™ Safety Syringe in the US

In an important advancement for medical safety, Terumo Medical Corporation, a wholly-owned subsidiary of Terumo Corporation, has announced the launch of its SurTract™ Safety Syringe in the United States. This innovative product is powered by Roncadelle Operations' revolutionary SafeR® passive safety technology. The SurTract Syringe is set to be distributed across various healthcare settings, including hospitals, clinics, and emergency care facilities, starting in the first quarter of 2026.

The introduction of the SurTract Syringe marks a significant improvement in patient safety and comfort during injections. Its design features a fully passive, automatic retraction mechanism that retracts the needle into the plunger immediately after use. This not only minimizes the risk of needle-stick injuries for healthcare providers but also reduces discomfort for patients due to decreased plunger pressure during injections.

Features and Benefits of the SurTract Syringe

1. Customizable Needle Selection: The product allows physicians to choose needle sizes specifically designed for use with the SurTract Syringes, enabling tailored care for their patients and optimizing treatment.
2. Blunt Needle Design: The syringe incorporates a blunt needle that prevents dullness and facilitates easy needle changes when drawing up aspirations.
3. Reduced Medical Waste: Due to the lack of an external plastic safety sheath, the SurTract Syringe contributes to significantly less medical waste compared to traditional syringes.
4. Medication Efficiency: With a low dead space design, the syringe minimizes medication waste, which is crucial for cost-effective medical treatment.

Bob Klock, the Vice President of Terumo Medical Corporation, emphasized the significance of the SurTract Syringe, stating, "The SurTract Syringe combines Terumo's trusted clinical expertise with Roncadelle's validated SafeR technology to enable a straightforward, effective solution for safer injections. This innovation provides healthcare professionals with enhanced treatment options for their patients, which is our ultimate goal."

Dr. Fred Metzmann, Chief Business Development Officer at Roncadelle Operations, also praised the collaboration, noting, "Terumo has made substantial advancements in injection safety with our SafeR technology. This partnership has led to a next-generation syringe system that is designed to be intuitive, reliable, and protective for healthcare professionals."

About Terumo and Roncadelle Operations

Founded in Tokyo in 1921, Terumo is a global leader in medical innovations, dedicated to enhancing healthcare worldwide. The company is committed to its mission of contributing to society through healthcare, operating in over 160 countries, and providing a wide range of solutions in therapeutic procedures, hospital operations, and life sciences.

On the other hand, Roncadelle Operations S.r.l. is based in Brescia, Italy, and specializes in developing and manufacturing advanced medical devices and pharmaceutical packaging. With a focus on safety and innovation, Roncadelle's SafeR® product line also includes passive safety syringes designed for safe injection practices and protection in clinical settings.

In conclusion, the SurTract™ Safety Syringe represents a significant leap forward in enhancing safety and comfort in medical injections. With its advanced features and design, healthcare providers can look forward to improved patient care and reduced risks associated with traditional syringes.